StevenFerencPolyakMD

Gastroenterology • Iowa City, IA

Advanced Endoscopic Interventional, Inflammatory Bowel Disease

University of Iowa

Join to view full profile

Dr. Polyak is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Polyak's full profile

Already have an account?

Office
200 Hawkins Dr
Iowa City, IA 52242
Phone+1 319-356-4901

Fax+1 319-384-8559

Summary

Dr. Steven Polyak is a gastroenterologist in Iowa City, IA and is affiliated with multiple hospitals in the area, including University of Iowa Hospitals and Clinics and Iowa City VA Health Care System. He received his medical degree from Mount Sinai School of Medicine and has been in practice 19 years. He specializes in advanced endoscopic interventional and inflammatory bowel disease and is experienced in general gastroenterology, inflammatory bowel disease, ulcerative colitis, and crohn's disease.

Education & Training

University of FloridaFellowship, Gastroenterology, 2001 - 2004
Vanderbilt University Medical CenterResidency, Internal Medicine, 1998 - 2001
Icahn School of Medicine at Mount SinaiClass of 1998

Certifications & Licensure

IA State Medical License 2010 - 2025
FL State Medical License 2004 - 2011
TN State Medical License 2000 - 2005
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis Start of enrollment: 2012 Feb 01
Completed
Phase 2
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis Start of enrollment: 2013 Nov 01
Terminated
Phase 2
A Study of CDPATH™ to Help Manage and Treat Crohn's Disease Start of enrollment: 2021 Jun 25
Active, not recruiting
Phase 4
Roles: Principal Investigator
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease Start of enrollment: 2024 Mar 05
Recruiting
Phase 2
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Clinical Long-Term Outcomes of Patient-Reported Outcomes in the Prospective Real-World Tofacitinib Response in Ulcerative Colitis Registry.
Hans H Herfarth, Anita Afzali, Monika Fischer, David Hudesman, Maisa Abdalla
Clinical and Translational Gastroenterology. 2024-03-01
Plaque-Like Lesions in the Gastrointestinal Tract.
Katelin Durham, Xiaocen Zhang, Yiqin Xiong, Aditi Reddy, Steven Polyak
ACG Case Reports Journal. 2023-08-01
13 citations
Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting.
Millie D Long, Anita Afzali, Monika Fischer, David Hudesman, Maisa Abdalla
Inflammatory Bowel Diseases. 2023-04-03